TREATMENT OF SYSTEMIC JUVENILE XANTHOGRANULOMA WITH IL-1 RECEPTOR ANTAGONIST ANAKINRA

被引：0
|
作者：
Akshintala, Srivandana [1 ]
Rossi, Christopher [2 ]
Ladisch, Stephan [1 ]
Greenberg, Jay [1 ]
机构：
[1] Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA
[2] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E70 / E70
页数：1
相关论文
共 50 条
  • [31] Novel multimeric IL-1 receptor antagonist for the treatment of rheumatoid arthritis
    Pasi, Shweta
    Kant, Ravi
    Gupta, Sarika
    Surolia, Avadhesha
    BIOMATERIALS, 2015, 42 : 121 - 133
  • [32] Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation
    Palmer, Gaby
    Talabot-Ayer, Dominique
    Kaya, Guerkan
    Gabay, Cem
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) : 1938 - 1946
  • [33] The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type IIL-1 receptor
    Irikura, VM
    Lagraoui, M
    Hirsh, D
    JOURNAL OF IMMUNOLOGY, 2002, 169 (01): : 393 - 398
  • [34] Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients
    Beynon, Celia
    Chin, Mei Fong
    Hunasehally, Prasad
    Bhagwandas, Krishnan
    Bevan, Martin
    Taylor, Marisa
    Lawson, Thomas
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (03) : 181 - 183
  • [35] IL-1 receptor antagonist as an aerosol in inflammation
    Ischenko, Alexander M.
    Nikolaev, Boris P.
    Kotova, Tatiana V.
    Vorobeychikov, Eugeny V.
    Konusova, Velentina G.
    Yakovleva, Ludmila Y.
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2007, 20 (04): : 445 - 459
  • [36] IL-1 RECEPTOR ANTAGONIST AND POSTMENOPAUSAL OSTEOPOROSIS
    PACIFICI, R
    VANNICE, JL
    BLOEDOW, DC
    THOMPSON, RB
    KIMBLE, R
    CLINICAL RESEARCH, 1992, 40 (03): : A735 - A735
  • [37] Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG
    Treudler, Regina
    Kauer, Friederike
    Simon, Jan Christoph
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (03) : 280 - 281
  • [38] IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis
    Gorelik, M.
    Lee, Y.
    Abe, M.
    Andrews, T.
    Davis, L.
    Patterson, J.
    Chen, S.
    Crother, T. R.
    Aune, G. J.
    Noval Rivas, M.
    Arditi, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 198 (01): : 101 - 110
  • [39] IL-1 ANTAGONIST ANAKINRA INHIBITS GLIOBLASTOMA PROLIFERATION BY ANTAGONIZING THE PROINFLAMMATORY MICROENVIRONMENT
    Effinger, David
    Huebner, Max
    Wu, Tingting
    Thon, Niklas
    Kreth, Friedrich-Wilhelm
    Kreth, Simone
    NEURO-ONCOLOGY, 2019, 21 : 257 - 257
  • [40] The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of the literature
    Giacomelli, R.
    Sota, J.
    Ruscitti, P.
    Campochiaro, C.
    Colafrancesco, S.
    Dagna, L.
    Iacono, D.
    Iannone, F.
    Lopalco, G.
    Sfriso, P.
    Cantarini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 187 - 195
12345